The Latest in Lymphoma & Plasma Cell Disorders

Fludarabine deemed important for CD30.CAR T-cell therapy

December 11, 2018

Mutation confers resistance to venetoclax in CLL

December 7, 2018

Two-drug combo deemed ‘very promising’ for PMBCL

December 6, 2018

Regimen provides survival benefit in PTCL

December 4, 2018

Update shows durable responses in rel/ref DLBCL

December 4, 2018

New PCNSL guidelines emphasize importance of patient fitness

December 2, 2018

FDA approves biosimilar rituximab for NHL

November 29, 2018

EC approves mogamulizumab for MF, SS

November 28, 2018

Pegfilgrastim biosimilar approved by EC

November 28, 2018

EC approves pegfilgrastim biosimilar

November 27, 2018

ASH expands late-breaking abstract session

November 26, 2018

CAR T-cell studies to be presented at ASH

November 24, 2018

Biosimilar deemed equivalent to rituximab in FL

November 21, 2018

Elderly NHL patients have higher NRM after HSCT

November 20, 2018

Americans concerned about cost of cancer care

November 20, 2018